Journal of the American Academy of Dermatology
-
J. Am. Acad. Dermatol. · Mar 2008
Case ReportsLeflunomide as adjuvant treatment of dermatomyositis.
We report 3 cases of recalcitrant dermatomyositis that responded to the addition of daily leflunomide, a novel immunomodulatory drug that is currently used to treat rheumatoid arthritis. In our patients, leflunomide proved both safe and effective as adjuvant therapy in treating dermatomyositis.
-
J. Am. Acad. Dermatol. · Mar 2008
Letter Case ReportsLongitudinal melanonychia as the first sign of Addison's disease.